Search for "dbv"

News Wire ~ 3rd Party Press Release - 2018/09/12 0

Part B expected to commence in 2018Q4 with Viaskin Peanut 250 µg.

Dave Bloom - 2018/02/28 0

Announcements regarding two food allergy therapies that are in or advancing toward clinical trials were made yesterday.

Dave Bloom - 2017/11/20 0

The trial met its primary objective, demonstrating that Viaskin Peanut was well-tolerated with no new or unexpected adverse events.

Dave Bloom - 2017/10/24 0

The Viaskin Peanut patch therapy still has 50:50 chance of approval according to research note.

Dave Bloom - 2017/03/22 1

The study received higher-than-expected patient demand.

Dave Bloom - 2017/03/07 0

The study model used common packaged foods such as cookies, ice cream, and doughnuts as references.

Dave Bloom - 2017/03/07 0

Pediatric patients responded with a favorable safety profile and no serious adverse effects.

Dave Bloom - 2016/10/25 0

The study was designed to assess the long-term efficacy and safety of the treatment in subjects that had graduated from their earlier VIPES trial.

Dave Bloom - 2016/06/13 0

The unique immune communication between skin and gastrointestinal tract can be used to generate long-lasting protection from food allergies.

Dave Bloom - 2016/03/07 5

We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.

dbv - search results